Description |
cyclin dependent kinase inhibitor 2C |
suppression of tumorigenicity 14 |
Image |
|
|
GO Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
|
- Adverse response to drug ( 30420678)
- Pre-treatment viral load in HIV-1 infection ( 31219150)
|
Interacting Genes |
51 interacting genes:
AHCYL1
AKT1
ANGPTL4
APLP1
ARNT
ATM
ATR
CCDC90B
CCND2
CCNE1
CDK4
CDK6
CDKN2A
CDKN2B
COPS6
DRAP1
EPHA2
ERBB2
FGFR4
GDF9
GOPC
GREB1
GRM1
LATS2
LNX2
LRIF1
LY96
MAP2K3
MAP2K5
MAPK10
MAPK8
MTA3
MYC
NAGK
NAT2
NF2
NIF3L1
PDGFRA
PPP2CA
RAF1
RBM48
REL
SCGB2A2
SNU13
ST14
STK11
TCF12
TCF4
TLE1
TP53
UNC119
|
17 interacting genes:
AKT1
APC
CASP8
CDCP1
CDKN2C
CHEK2
F2RL1
HGF
NOTCH2
PDGFC
PHB
PLAU
RAD51
RGS16
SPINT1
STK11
TGFB1
|
Entrez ID |
1031 |
6768 |
HPRD ID |
04534 |
06005 |
Ensembl ID |
ENSG00000123080
|
ENSG00000149418
|
Uniprot IDs |
P42773
Q6ICV4
|
Q9Y5Y6
|
PDB IDs |
1BU9
1G3N
1IHB
1MX2
1MX4
1MX6
|
1EAW
1EAX
2FMV
2GV6
2GV7
3BN9
3NCL
3NPS
3P8F
3P8G
3SO3
4IS5
4ISL
4ISN
4ISO
4JYT
4JZ1
4JZI
4O97
4O9V
4R0I
5LYO
6N4T
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|